Beta Drugs Ltd

Beta Drugs Ltd | Sector: Pharmaceuticals | ISIN: INE351Y01019

₹ 640.00 (2.35%) icon

9 Feb, 2023, 3:24:49 PM
Open
₹ 699.00
Prev. Close
₹ 625.30
Turnover(lac)
₹ 16.64
Day's High
₹ 699.00
Day's Low
₹ 636.00
52 Wk High
₹ 1,024.40
52 Wk Low
₹ 486.35
Book Value
₹ 0.00
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 615.28
P/E
42.19
EPS
14.82
Div. Yield
0.00

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/9/2023 3:24:49 PM

    ₹ 640 14.70 2.35
  • Open
  • ₹ 699
  • Prev. Close
  • ₹ 625.3
  • Turnover(Lac.)
  • ₹ 17
  • Day's High
  • ₹ 699
  • Day's Low
  • ₹ 636
  • 52 Week's High
  • ₹ 1,024.4
  • 52 Week's Low
  • ₹ 486.35
  • Book Value
  • ₹ 0
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 615.28
  • P/E
  • 42.19
  • EPS
  • 14.82
  • Divi. Yield
  • 0

Corporate Actions

17 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Aug , 2022

12:00 AM

AGM

Announcement date: 30 Aug , 2022

View Details

30 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Aug , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
09 February , 2023 | 03:31 PM

PROMOTER - TOTAL66.71%

Indian: 66.71%

Foreign: 0%

NON-PROMOTER - TOTAL 33.29%

Institutions: 0.33%

Non-Institutions: 32.96%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Beta Drugs Ltd News and Update

Image not found
  • 01 February, 2023 |
  • 2:50 PM

Today's Budget has every potential to bring out a broad-based revival in the Indian economy.

Image not found
Image not found
Article Image
  • IIFL News Service |
  • 30 January, 2023 |
  • 2:47 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Beta Drugs Ltd

  • Balwant Singh.

  • Whole-time Director
  • Varun Batra

  • Whole-time Director
  • Rahul Batra

  • Whole-time Director
  • Manmohan Khanna

  • Independent Director
  • Rohit Parti

  • Independent Director
  • Rajni Brar

  • Company Secretary
  • Seema Chopra

  • Whole-time Director
  • Neeraj Batra

  • Director
  • Ashutosh Shukla

  • Additional Director

Summary

Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to Beta Drugs Limited on August 11, 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Companys products range from anti-cancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. As on March 31, 2017, the company had a portfolio of over 50 products catering to various oncology diseases including breast, brain, bone, lung, mouth, head & neck, prostate, haematology, cervics, oeaophagus... Read More


Reports by Beta Drugs Ltd


Reports by Beta Drugs Ltd